Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

MedWellAI (MWAI) EBIAT (2016 - 2026)

MedWellAI has reported EBIAT over the past 12 years, most recently at -$287519.0 for Q4 2025.

  • Quarterly EBIAT rose 60.6% to -$287519.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Dec 2025, up 50.69% year-over-year, with the annual reading at -$2.9 million for FY2025, 74.4% up from the prior year.
  • EBIAT was -$287519.0 for Q4 2025 at MedWellAI, up from -$653607.0 in the prior quarter.
  • Over five years, EBIAT peaked at $1.3 million in Q3 2021 and troughed at -$22.1 million in Q2 2023.
  • The 5-year median for EBIAT is -$746628.5 (2022), against an average of -$3.2 million.
  • The largest YoY upside for EBIAT was 446.59% in 2021 against a maximum downside of 3630.14% in 2021.
  • A 5-year view of EBIAT shows it stood at -$515261.0 in 2021, then crashed by 48.2% to -$763597.0 in 2022, then skyrocketed by 52.91% to -$359564.0 in 2023, then crashed by 102.93% to -$729660.0 in 2024, then surged by 60.6% to -$287519.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EBIAT are -$287519.0 (Q4 2025), -$653607.0 (Q3 2025), and -$471112.0 (Q2 2025).